Contact this trialFirst, we need to learn more about you.
Antiplatelet Agent
Rivaroxaban + Aspirin for Blood Clot Prevention After Joint Surgery
Recruiting4 awardsPhase 3
Halifax, Nova Scotia
This trial will test whether adding rivaroxaban to aspirin helps prevent venous thromboembolism better than aspirin alone in patients undergoing hip or knee replacement surgery.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service